[Endocrinologic aspects of male infertility].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3928456)

Published in Gynakologe on June 01, 1985

Authors

U A Knuth, E Nieschlag

Articles by these authors

A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38

Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78

Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell (1995) 2.89

Lifespan and testosterone. Nature (1993) 2.84

Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature (1996) 2.63

The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev (1997) 2.44

Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism. Hum Reprod (1997) 2.23

Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum Reprod (1998) 2.10

Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98

Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod (2000) 1.96

External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65

Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod (1999) 1.61

Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61

Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60

Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55

Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab (1997) 1.54

Cryopreservation of semen from adolescent patients with malignancies. Med Pediatr Oncol (1996) 1.53

Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. Hum Mol Genet (2000) 1.53

Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil Steril (1995) 1.45

Sonographic testicular microlithiasis as an indicator of premalignant conditions in normal and infertile men. J Androl (2001) 1.45

Objective identification of hyperactivated human spermatozoa by computerized sperm motion analysis with the Hamilton-Thorn sperm motility analyser. Hum Reprod (1990) 1.42

A portable digital data recorder for long-term monitoring of scrotal temperatures. Fertil Steril (1990) 1.42

The epididymis and male fertility. A symposium report. Int J Androl (1986) 1.41

The effect of bradykinin and the bradykinin antagonist Hoe 140 on kinematic parameters of human spermatozoa. Int J Androl (1996) 1.40

[The Kallmann syndrome. Its pathophysiology and clinical picture]. Dtsch Med Wochenschr (1994) 1.39

Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet (1997) 1.38

Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet (1984) 1.36

Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31

Isoforms and single nucleotide polymorphisms of the FSH receptor gene: implications for human reproduction. Hum Reprod Update (2002) 1.30

Germ cell transfer into rat, bovine, monkey and human testes. Hum Reprod (1999) 1.30

Testosterone levels in healthy men and the relation to behavioural and physical characteristics: facts and constructs. Eur J Endocrinol (2001) 1.30

Plasma androgen levels in men after oral administration of testosterone or testosterone undecanoate. Acta Endocrinol (Copenh) (1975) 1.26

Germ cell transplantation into X-irradiated monkey testes. Hum Reprod (2002) 1.25

Partial deletions in the AZFc region of the Y chromosome occur in men with impaired as well as normal spermatogenesis. Hum Reprod (2004) 1.24

Inhibin B in male reproduction: pathophysiology and clinical relevance. Eur J Endocrinol (2001) 1.24

ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22

Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab (1999) 1.20

Testicular sperm extraction: comprehensive analysis with simultaneously performed histology in 1418 biopsies from 766 subfertile men. Hum Reprod (1999) 1.19

Objective measurement of testicular volume by ultrasonography: evaluation of the technique and comparison with orchidometer estimates. Int J Androl (1989) 1.17

Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab (1982) 1.17

Post-"pill" amenorrhoea--cause or coincidence? Br Med J (1977) 1.15

The structure and organization of the human follicle-stimulating hormone receptor (FSHR) gene. Genomics (1996) 1.14

Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril (2000) 1.14

First human exposure to FSH-CTP in hypogonadotrophic hypogonadal males. Hum Reprod (2001) 1.12

Experience with external quality control in spermatology. Hum Reprod (1999) 1.11

Steroid hormones and their binding in plasma of male patients with fatty liver, chronic hepatitis and liver cirrhosis. Acta Endocrinol (Copenh) (1975) 1.11

Phenotypic variation within European carriers of the Y-chromosomal gr/gr deletion is independent of Y-chromosomal background. J Med Genet (2008) 1.10

The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia (2002) 1.10

A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab (2005) 1.09

Amenorrhoea and loss of weight. Br J Obstet Gynaecol (1977) 1.07

Semen analysis and external quality control schemes for semen analysis need global standardization. Int J Androl (2002) 1.06

Evaluation of the semi-automated Autosperm semen analysis system. I. Accuracy and comparison with the conventional method and the automated Hamilton-Thorn system. Fertil Steril (1990) 1.06

Clinical experience with azoospermia: aetiology and chances for spermatozoa detection upon biopsy. Int J Androl (2010) 1.06

Spontaneous recrudescence of spermatogenesis in the photoinhibited male Djungarian hamster, Phodopus sungorus. Biol Reprod (1995) 1.06

Serum FSH and testicular morphology in male infertility. Clin Endocrinol (Oxf) (1994) 1.05

Screening for deletions of the Y chromosome involving the DAZ (Deleted in AZoospermia) gene in azoospermia and severe oligozoospermia. Fertil Steril (1997) 1.05

The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab (2001) 1.04

Anabolic steroids and semen parameters in bodybuilders. Fertil Steril (1989) 1.04

Successful testicular sperm extraction (TESE) in spite of high serum follicle stimulating hormone and azoospermia: correlation between testicular morphology, TESE results, semen analysis and serum hormone values in 103 infertile men. Hum Reprod (1998) 1.03

Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab (2000) 1.03

Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years. Clin Endocrinol (Oxf) (1999) 1.03

An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J Clin Endocrinol Metab (1996) 1.03

Influence of short photoperiods on reproductive organs and estrous cycles of normal and pinealectomized female Djungarian hamsters, Phodopus sungorus. Biol Reprod (1993) 1.02

Internal quality control of semen analysis. Fertil Steril (1992) 1.02

Serum inhibin B in combination with serum follicle-stimulating hormone (FSH) is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab (1999) 1.02

Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection--prevalence, types, sex distribution and reproductive relevance. Hum Reprod (1998) 1.01

The Old World monkey DAZ (Deleted in AZoospermia) gene yields insights into the evolution of the DAZ gene cluster on the human Y chromosome. Hum Mol Genet (1999) 1.00

Identification of male germ cells undergoing apoptosis in adult rats. J Reprod Fertil (1995) 0.99

Update on medical treatment of ejaculatory disorders. Int J Androl (2002) 0.98

Hormone substitution in male hypogonadism. Mol Cell Endocrinol (2000) 0.98

The effects of different cumulative doses of chemotherapy on testicular function. Results in 75 patients treated for Hodgkin's disease during childhood or adolescence. Cancer (1990) 0.98

Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J (1998) 0.97

Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol (1998) 0.97

Role of FSH in male gonadal function. Ann Endocrinol (Paris) (1999) 0.97

Case report: natural transmission of an AZFc Y-chromosomal microdeletion from father to his sons. Hum Reprod (2004) 0.97

Y-chromosomal microdeletions and partial deletions of the Azoospermia Factor c (AZFc) region in normozoospermic, severe oligozoospermic and azoospermic men in Sri Lanka. Asian J Androl (2006) 0.97

Decreasing sperm counts? A critical (re)view. Exp Clin Endocrinol Diabetes (1996) 0.96

The secretion of dehydroepiandrosterone and dehydroepiandrosterone sulphate in man. J Endocrinol (1973) 0.96

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol (Oxf) (1994) 0.96

The cause of infertility of male c-ros tyrosine kinase receptor knockout mice. Biol Reprod (2000) 0.96

Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol (1996) 0.95

Sperm aneuploidy rates in younger and older men. Hum Reprod (2002) 0.95

Investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Androl (2008) 0.94

Appearance of alpha-smooth muscle actin in peritubular cells of monkey testes is induced by androgens, modulated by follicle-stimulating hormone, and maintained after hormonal withdrawal. J Androl (1994) 0.94

Effect of ketoconazole and other imidazole fungicides on testosterone biosynthesis. Acta Endocrinol (Copenh) (1984) 0.93

Salivary testosterone in men: further evidence of a direct correlation with free serum testosterone. J Clin Endocrinol Metab (1981) 0.93

Changes in movement characteristics of human spermatozoa along the length of the epididymis. Biol Reprod (1993) 0.93

Prevalence of Y chromosome microdeletions in infertile men who consulted a tertiary care medical centre: the Münster experience. Andrologia (2001) 0.92

'9 + 0' axoneme in spermatozoa and some nasal cilia of a patient with totally immotile spermatozoa associated with thickened sheath and short midpiece. Hum Reprod (1990) 0.92

Suppression of endogenous testosterone in young men increases serum levels of high density lipoprotein subclass lipoprotein A-I and lipoprotein(a). J Clin Endocrinol Metab (1997) 0.92

Radioimmunoassay for plasma testosterone. Z Klin Chem Klin Biochem (1972) 0.91

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. Eur J Endocrinol (1999) 0.91

Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab (2001) 0.90

Basal cells of the human epididymis--antigenic and ultrastructural similarities to tissue-fixed macrophages. Biol Reprod (1994) 0.90

Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception. J Clin Endocrinol Metab (2001) 0.90

Semen parameters and testicular pathology in men with testicular cancer and contralateral carcinoma in situ or bilateral testicular malignancies. Hum Reprod (1997) 0.90

Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis). Fertil Steril (1984) 0.90

FSH and testosterone, alone or in combination, initiate testicular growth and increase the number of spermatogonia and Sertoli cells in a juvenile non-human primate (Macaca mulatta). J Endocrinol (1993) 0.89

Dazl protein expression in adult rat testis is up-regulated at meiosis and not hormonally regulated. Int J Androl (2000) 0.89